Changes of macrovascular endothelial ultrastructure and gene expression of endothelial nitric oxide synthase in diabetic rats

Chinese Medical Journal

Volumn 117, Issue 8, 2004, Pages 1165-1169

  Lu, Ying Li ^a   Hu, Shen Jiang ^b   Shen, Zhou Jun ^b   Shao, Yi Chuan ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Diabetes mellitus; eNOSmRNA; Macrovascular; Ultrastructure

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUTARALDEHYDE; LIQUID NITROGEN; MESSENGER RNA; STREPTOZOCIN;

ABDOMINAL AORTA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA WALL; ARTICLE; ATHEROGENESIS; BODY WEIGHT; CLINICAL OBSERVATION; CONTROLLED STUDY; DENATURATION; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DISEASE SEVERITY; ENDOTHELIUM LESION; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; MALE; NONHUMAN; PATHOPHYSIOLOGY; QUANTITATIVE ANALYSIS; RAT; RAT STRAIN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCANNING ELECTRON MICROSCOPY; STATISTICAL SIGNIFICANCE; STREPTOZOCIN DIABETES; TISSUE FIXATION; TISSUE PRESERVATION; VASCULAR ENDOTHELIUM;

ANIMALS; AORTA, ABDOMINAL; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; ENDOTHELIUM, VASCULAR; FEMALE; MALE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SEX FACTORS; STREPTOZOCIN;

EID: 4444331071     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 2002;287:2570-2581.
2. Skrha J. Diabetes mellitus--a risk factor for cardiovascular diseases. Vnitr Lek 2001;47:281-284.
3. Steg PG, Karila-Cohen D, Feldman LJ. The coronary atherosclerosis of the diabetic. Arch Mal Coeur Vaiss 2000; 93:19-24.
4. Johasen OE, Birkerland KI. Preventing macrovascular disease in patients weith tpye 2 diabetes mellitus. Am J Cardiovasc Drugs 2003;3:283-297.
5. Goraya TY, Leibson CL, Palumbo PJ, et al. Coronary atherosclerosis in diabetes mellitus: a population-based autopsy study. J Am Coll Cardiol 2002;40:946-953.
6. Turtle JR. The economic burden of insulin resistance. Int J Clin Pract Suppl 2000;113:23-28.
7. Plante GE. Vascular response to stress in health and disease. Metabolism 2002;51(6 Suppl 1):25-30.
8. Ceriello A, Taboga C, Tonutti L, et al. Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: effects of short-and long-term simvastatin treatment. Circulation 2002;106: 1211-1218.
9. Lee SJ, Lee DW, Kim KS, et al. Effect of estrogen on endothelial dysfunction in postmenopausal women with diabetes. Diabetes Res Clin Pract 2001;54 (Suppl 2):S81-S92.
10. Pieper GM. Acute amelioration of diabetic endothelial dysfunction with a derivative of the nitric oxide synthase cofactor, tetrahydrobiopterin. J Cardiovase Pharmacol 1997; 29:8-15.
11. Lin KY, Ito A, Asagami T, et al. Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylamimohydrolase. Circulation 2002;106:987-992.
12. Federici M, Menghini R, Mauriello A, et al. Insulin-dependent activation of endothelial nitric oxide synthase is impaired by O-linked glycosylation modification of signaling proteins in human coronary endothelial cells. Circulation 2002;106:466-472.
13. Du XL, Edelstein D, Dimmeler S, et al. Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. J Clin Invest 2001;108:1341-1348.
14. Pieper GM, Siebeneich W, Olds CL, et al. Vascular protective actions of a nitric oxide aspirin analog in both in vitro and in vivo models of diabetes mellitus. Free Radic Biol Med 2002;32:1143-1156.